Mapping thyroid-related heart scarring with new imaging
Part of Heart & circulation clinical trials.
This study tests a new imaging method to measure tiny scars in the heart caused by chronic thyroid disease. It may help doctors detect heart damage earlier without using needles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a chronic thyroid condition, such as hypothyroidism or hyperthyroidism.
- You do not have other chronic illnesses like diabetes or high blood pressure.
- You have never received radiation therapy to your neck.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
This trial uses a special imaging technique to look at the tiny blood vessels inside thyroid nodules before they are removed. It may help doctors understand which nodules are cancerous.
This study tests a new way to use heart MRI to find scarring (fibrosis) in the heart muscle. It may help doctors detect heart damage more accurately.
This study looks at whether measuring blood pressure in a new way (central BP) can help predict heart disease risk in people with mild underactive thyroid (subclinical hypothyroidism). It may help doctors better understand your heart health without extra tests.
This trial tests a new ultrasound probe designed to take better images of thyroid nodules. It may help improve the monitoring of nodules over time.
This study tests if a man-made hormone (rhTSH) can make radioactive iodine therapy more effective for people with advanced thyroid cancer that has come back or spread. It aims to see if it helps find and treat cancer that doesn't respond well to standard radioactive iodine.
Hear when a new Chronic Thyroid Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.